Human papillomavirus prevalence and vaccine effectiveness in young women in Germany, 2017/2018: results from a nationwide study

Human papillomavirus prevalence and vaccine effectiveness in young women in Germany, 2017/2018: results from a nationwide study

BackgroundInfections with human papillomaviruses (HPV) are sexually transmitted and can cause cancer. In Germany, vaccination against HPV is recommended for girls and boys aged 9–17 years. We aimed to investigate HPV DNA prevalence, genotype distribution and vaccine effectiveness (VE) in women aged...

Full description

Bibliographic Details
Main Authors: Anna Loenenbach, Viktoria Schönfeld, Anja Takla, Miriam Wiese-Posselt, Adine Marquis, Sarah Thies, Matthias Sand, Andreas M. Kaufmann, Ole Wichmann, Thomas Harder
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-08-01
Series:Frontiers in Public Health
Subjects:
population-based study
cervical cancer prevention
self-sampling
HPV genotyping
vaccine effectiveness
prevalence
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2023.1204101/full

Internet

https://www.frontiersin.org/articles/10.3389/fpubh.2023.1204101/full

Similar Items